Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

PublicNYSEMKT:ONVO
Date2/2012
Raised$46.6M
Post IPO Valuation

General Information

Offices

San Diego, USA
6275 Nancy Ridge Drive
Suite 110
San Diego, CA, 92121
USA

People

CFO
Chairman and CEO
CTO&Executive Vice President

Funding

TOTAL $26.4M
FUNDING TOTAL $26.4M
Series A, 11/2011
$3.49M
Private Equity, 3/2012
Spencer Trask
$15.2M
Seed, 1/2013
$7.66M

Competitors

Tags

Organovo Holdings

Organovo is focused on delivering breakthrough three-dimensional biology capabilities to create tissue on demand for research and surgical applications. As the first company with a three-dimensional tissue technology that works across tissue types, they are meeting the promise of regenerative medicine to fill unmet medical needs.

Recent Milestones

Videos

Screenshots

Organovo Holdings screenshot
Above: Organovo
Uploaded: 12/19/12

Stock Price

Sources

  1. SEC (sec.gov) [edit]
  2. Organovo Press Release (ir.organovo.com) [edit]
  3. SEC (sec.gov) [edit]
Edit This Page
Last Edited 3/28/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy